Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder

Journal of Clinical Psychiatry

Volumn 73, Issue 6, 2012, Pages 843-848

  Mischoulon, David ^a   Alpert, Jonathan E ^a   Arning, Erland ^b   Bottiglieri, Teodoro ^b   Fava, Maurizio ^a   Papakostas, George I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BAYLOR RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; METHIONINE; PLACEBO; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; DSM-IV; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; METABOLIC PARAMETERS; ONE CARBON CYCLE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SCORING SYSTEM;

EID: 84863557233     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07139     Document Type: Article

References (27)

1. Papakostas GI. Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder. J Clin Psychiatry. 2009; 70(suppl 5):18-22. doi:10.408/JCP.8157su1c.04 PubMed
2. Mischoulon D, Fava M. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr. 2002;76(5):1158S-1161S. PubMed (Pubitemid 35244695)
3. Lieber CS. S-adenosyl-L-methionine: its role in the treatment of liver disorders. Am J Clin Nutr. 2002;76(5):1183S-1187S. PubMed (Pubitemid 35244699)
4. Suchy J, Lee S, Ahmed A, et al. Dietary supplementation with S-adenosyl methionine delays the onset of motor neuron pathology in a murine model of amyotrophic lateral sclerosis. Neuromolecular Med. 2010; 12(1):86-97. doi:10.107/s12017-09-8089-7 PubMed
5. Maes M, Galecki P, Chang YS, et al. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(3):676-692. doi:10.1016/j.pnpbp. 2010.05.04 PubMed
6. Chung YC, Kim SR, Jin BK. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease. J Immunol. 2010; 185(2):1230-1237. doi:10.4049/jimunol.10208 PubMed
7. Vismari L, Alves GJ, Palermo-Neto J. Amitriptyline and acute inflammation: a study using intravital microscopy and the carrageenan-induced paw edema model. Pharmacology. 2010;86(4):231-239. doi:10.159/0317064 PubMed
8. Tulner DM, Smith OR, Schins A, et al. Antidepressive effect of mirtazapine in post-myocardial infarction depression is associated with soluble TNF-R1 increase: data from the MIND-IT. Neuropsychobiology. 2011;63(3):169-176. doi:10.159/0321624 PubMed
9. Leonard BE. The concept of depression as a dysfunction of the immune system. Curr Immunol Rev. 2010;6(3):205-212. PubMed doi:10.2174/ 15739510791823835
10. Bottiglieri T. S-Adenosyl-L-methionine (SAMe): from the bench to the bedside - molecular basis of a pleiotrophic molecule. Am J Clin Nutr. 2002;76(5):1151S-1157S. PubMed (Pubitemid 35244694)
11. Still RA, McDowell IF. ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease. J Clin Pathol. 1998;51(3):183-188. doi:10.136/jcp.51.3.183 PubMed
12. Alpert JE, Papakostas GI, Mischoulon D. One-carbon metabolism and the treatment of depression: roles of S-adenosyl-L-methionine and folate. In: Mischoulon D, Rosenbaum J, eds. Natural Medications for Psychiatric Disorders: Considering the Alternatives. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:68-83.
13. Frasure-Smith N, Lespérance F, Habra M, et al. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation. 2009;120:134-140. PubMed
14. Gören JL, Stoll AL, Damico KE, et al. Bioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humans. Pharmacotherapy. 2004; 24(11):1501-1507. doi:10.1592/phco.24.16.1501.50943 PubMed (Pubitemid 39426345)
15. Alpert JE, Papakostas G, Mischoulon D, et al. S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine. J Clin Psychopharmacol. 2004;24(6):661-664. doi:10.1097/01.jcp. 014539.45794.cd PubMed (Pubitemid 39518665)
16. Papakostas GI, Mischoulon D, Shyu I, et al. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am J Psychiatry. 2010;167(8):942-948. doi:10.176/api.ajp.209.0908198 PubMed
17. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
18. Struys EA, Jansen EE, de Meer K, et al. Determination of S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid by stable-isotope dilution tandem mass spectrometry. Clin Chem. 2000;46(10):1650-1656. PubMed
19. Ducros V, Belva-Besnet H, Casetta B, et al. A robust liquid chromatography tandem mass spectrometry method for total plasma homocysteine determination in clinical practice. Clin Chem Lab Med. 2006;44(8):987-990. doi:10.1515/CLM.206.178 PubMed (Pubitemid 44155869)
20. Nelson BC, Pfeiffer CM, Margolis SA, et al. Solid-phase extraction-electrospray ionization mass spectrometry for the quantification of folate in human plasma or serum. Anal Biochem. 2004;325(1):41-51. doi:10.1016/j.ab.203.10.09 PubMed (Pubitemid 38050265)
21. Loehrer FM, Angst CP, Haefeli WE, et al. Low whole-blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease. Arterioscler Thromb Vasc Biol. 1996;16(6):727-733. doi:10.161/01.ATV.16.6.727 PubMed
22. Stegink LD, Filer LJ Jr, Baker GL. Plasma methionine levels in normal adult subjects after oral loading with L-methionine and N-acetyl-L-methionine. J Nutr. 1980;110(1):42-49. PubMed (Pubitemid 10145983)
23. Kennedy BP, Bottiglieri T, Arning E, et al. Elevated S- adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function. J Neural Transm. 2004;111(4):547-567. doi:10.107/s0702-03- 096-5 PubMed (Pubitemid 38478922)
24. Yang J, He Y, Du YX, et al. Pharmacokinetic properties of S-adenosylmethionine after oral and intravenous administration of its tosylate disulfate salt: a multiple-dose, open-label, parallel-group study in healthy Chinese volunteers. Clin Ther. 2009;31(2):311-320. doi:10.1016/j.clinthera.209. 02.010 PubMed
25. Solvason HB, DeBattista C. Antidepressant dosing for the acute treatment of unipolar depression. Prim Psychiatry. 2009;16(10):30-36.
26. Leuchter AF, Cook IA, Hamilton SP, et al. Biomarkers to predict antidepressant response. Curr Psychiatry Rep. 2010;12(6):553-562. doi:10.107/s1920-010-0160-4 PubMed
27. Bartova L, Berger A, Pezawas L. Is there a personalized medicine for mood disorders? Eur Arch Psychiatry Clin Neurosci. 2010; 260(suppl 2):S121-S126. doi:10.107/s0406-010-0152-8 PubMed